Advertisement

Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer

      Abstract

      Objective

      To determine if the timing of radical cystectomy for variant histology of urothelial carcinoma has an impact on survival. Variant histology has been associated with aberrant behavior compared to pure urothelial carcinoma, however the timing of surgery for these patients has not been studied.

      Materials and Methods

      We identified 363 patients with cT2-T4N0M0 urothelial carcinoma who underwent radical cystectomy without perioperative intravesical and/or systemic therapy from 2003 to 2014. Clinicopathologic data were compared between pure urothelial carcinoma and variant histology. The time from diagnosis to radical cystectomy was analyzed as a continuous variable and dichotomized at 4-, 8-, and 12-weeks to determine impact on oncologic outcomes.

      Results

      Patients with variant histology, when compared to those with pure urothelial carcinoma, were more likely to present with extravesical disease (P <.01), be upstaged (P <.01), have lymphovascular invasion (P <.01) and have lymph node metastasis at radical cystectomy (P = .02). The median days to radical cystectomy did not differ between pure urothelial and variant histology. On multivariable analysis controlling for age, comorbidities, tumor stage, lymph node status, lymphovascular invasion, and surgical margins, every month in delay was associated with a worse overall survival for variants (HR = 1.36, P = .003). At an 8-week delay or longer, those with variant histology had a statistically worse survival (P = .03).

      Conclusion

      For patients with variant histology, delays in surgery were associated with an increased risk of death.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Siegel RL
        • Miller KD
        • Jemal A
        Cancer statistics, 2018.
        CA Cancer J Clin. 2018; 68: 7
        • Stein JP
        • Lieskovsky G
        • Cote R
        • et al.
        Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.
        J Clin Oncol. 2011; 19: 666
        • Shariat SF
        • Karakiewicz PI
        • Palapattu GS
        • et al.
        Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium.
        J Urol. 2006; 176: 2414
        • Grossman HB
        • Natale RB
        • Tangen CM
        • et al.
        Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.
        N Engl J Med. 2003; 349: 859
        • Wasco MJ
        • Daignault S
        • Zhang Y
        • et al.
        Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection.
        Urology. 2007; 70: 69
        • Black PC
        • Brown GA
        • Dinney CPN
        The impact of variant histology on the outcome of bladder cancer treated with curative intent.
        Urol Oncol Semin Orig Investig. 2009; 27: 3
        • Amin MB.
        Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications.
        Mod Pathol. 2009; 22: 96
        • Moschini M
        • Dell'Oglio P
        • Luciano’ R
        • et al.
        Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy.
        Urol Oncol Semin Orig Investig. 2017; 35: 335
        • Kulkarni GS
        • Urbach DR
        • Austin PC
        • et al.
        Longer wait times increase overall mortality in patients with bladder cancer.
        J Urol. 2009; 182: 1318
        • Sanchez-Ortiz RF
        • Huang WC
        • Mick R
        • et al.
        An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma.
        J Urol. 2003; 169: 110
        • Gore J
        • Lai J
        • Setodji C
        • et al.
        Mortality increases when radical cystectomy is delayed more than 12 weeks.
        Cancer. 2009; 115: 988
        • Fahmy NM
        • Mahmud S
        • Aprikian AG
        Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature.
        Eur Urol. 2006; 50: 1176
        • Mahmud SM
        • Fong B
        • Fahmy N
        • et al.
        Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study.
        J Urol. 2006; 175: 78
        • Lee CT
        • Madii R
        • Daignault S
        • et al.
        Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival.
        J Urol. 2006; 175: 1262
        • Chang SS
        • Hassan MJ
        • Cookson MS
        • et al.
        Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage.
        J Urol. 2003; 170: 1085
        • Liedberg F
        • Anderson H
        • Mansson W
        Treatment delay and prognosis in invasive bladder cancer.
        J Urol. 2005; 174: 1777
        • Nielsen ME
        • Palapattu GS
        • Karakiewicz PI
        • et al.
        A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome.
        BJU Int. 2007; 100: 1015
        • Bruins HM
        • Aben KKH
        • Arends TJ
        • et al.
        The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
        Urol Oncol Semin Orig Investig. 2016; 34 (e1): 166
        • Eble JN
        • Sauter G
        • Epstein JI
        • et al.
        Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs.
        3rd ed. IARC Press, Lyon, France2004
        • Sobin LH
        • Fleming ID.
        TNM classification of malignant tumors, fifth edition (1997).
        Cancer. 1997; 80: 1803
        • Chalasani V
        • Chin JL
        • Izawa JI
        Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.
        Can Urol Assoc J. 2009; 3: S193
        • Xylinas E
        • Rink M
        • Robinson BD
        • et al.
        Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
        Eur J Cancer. 2013; 49: 1889
        • Soave A
        • Riethdorf S
        • Dahlem R
        • et al.
        Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
        BJU Int. 2017; 119: 854
        • Soave A
        • Riethdorf S
        • Dahlem R
        • et al.
        A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy.
        Int J Cancer. 2017; 140: 381
        • Park JC
        • Gandhi NM
        • Carducci MA
        • et al.
        A Retrospective analysis of the effect on survival of time from diagnosis to neoadjuvant chemotherapy to cystectomy for muscle invasive bladder cancer.
        J Urol. 2016; 195: 880
        • Vetterlein MW
        • Wankowicz SAM
        • Seisen T
        • et al.
        Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
        Cancer. 2017; 123: 4346
        • Ge P
        • Wang Z-C
        • Yu X
        • et al.
        Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
        BMC Urol. 2015; 15: 46
        • Abd el-Latif A
        • Watts KE
        • Elson P
        • et al.
        The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy.
        J Urol. 2013; 189: 1263
        • Shah RB
        • Montgomery JS
        • Montie JE
        • et al.
        Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a large referral hospital.
        Urol Oncol Semin Orig Investig. 2013; 31: 1650
        • Chang SS
        • Bochner BH
        • Chou R
        • et al.
        Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline.
        J Urol. 2017; 198: 552